|
tbar.gif
Click
here to
submit entries
|
|
|
Bad Cancer Tests
Drawing Scrutiny |
January
4, 2008--Studies in recent years
have shown that certain lab tests widely used to determine which drugs are
prescribed for breast-cancer patients are often inaccurate. The tests
require pathologists to make judgment calls based on their microscopical
examination of tissue. Concern about inconsistent test results among labs
could fuel the push for increased oversight of the US lab-testing
business. US labs, which are regulated by the Centers for Medicare and
Medicaid Services, currently must pass outside proficiency checks on 83
types of tests; the breast-cancer tests in question are not on this list. The
Wall Street Journal (Subscription required)
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
